European drug regulator fears return to days of data secrecy
The agency that regulates drugs in Europe is nervously awaiting the outcome of an industry driven court case that aims to curb public access to clinical trial documents.Two drug companies have argued…
Read Original Article: European drug regulator fears return to days of data secrecy »
